article thumbnail

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

STAT

Krystal, who worked for both Yale and the VA at the time, and his co-inventors applied for patents with VA funding starting in 2006 for a ketamine nasal spray to treat depression and suicidal ideation. Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions.

article thumbnail

China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData

Express Pharma

Hefei Tianhui Biotechnology (HTIT) has recently submitted a marketing authorisation application (MAA) in China for the world’s first oral insulin for type 2 diabetes (T2D). The number of diagnosed prevalent cases of type 2 diabetes in China is estimated to grow at a CAGR of 2.21 per cent from 57.4 million in 2022 to 63.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HCP Perspectives: Access Challenges in Treating Diabetes & Obesity

Drug Channels

They discussed new GoodRx research and had a candid discussion about their daily challenges in caring for patients—especially those living with diabetes and obesity. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to watch the full video of the conversation between Drs.

article thumbnail

GoodRx Announces New Way for Consumers To Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

Drug Channels

This program will increase affordabiliy and broaden access for people living with diabetes. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Read on for Dorothy’s insights. d/b/a Drug Channels Institute.

article thumbnail

The Economics of Copay Accumulators, Maximizers, and Alternative Funding Programs (Video) (rerun)

Drug Channels

IMHO, this was a huge win for patients thanks to the HIV + Hepatitis Policy Institute, the Diabetes Patient Advocacy Coalition, and the Diabetes Leadership Council. Copyright © 2006-2023 Pembroke Consulting, Inc. Details and industry reactions here. We apologize for the error. d/b/a Drug Channels Institute.

article thumbnail

Drug Channels News Roundup, July 2020: Diabetes Costs, Regeneron’s Copay Support, MA Rethinks Coupons, My Favorite Chart Updated, and ABC’s Steve Collis

Drug Channels

In this issue: Pricing problems for diabetes treatments Controversy over Regeneron’s copay support Massachusetts concedes that coupons help some patients (but accumulators hurt) A 2020 update to my all-time favorite chart Plus, thoughtful perspectives on diversity from AmerisourceBergen CEO Steve Collis. d/b/a Drug Channels Institute.

article thumbnail

Sandoz to file for approval of aflibercept biosimilar

European Pharmaceutical Review

Aflibercept is injected into the eye of patients with neovascular retinal diseases, like neovascular age-related macular degeneration (nAMD), diabetic macular edema ( DME ), or retinal vein occlusion (RVO), to improve visual acuity and inhibit disease progression.